DarioHealth Corp. (NASDAQ:DRIO)
Industry: Healthcare

DarioHealth Corp., a digital health company, develops and commercializes patented and proprietary technologies providing consumers with laboratory-testing capabilities using smart phones and other mobile devices in the United States, Europe, Australia, and Canada. The company's flagship product, Dario, also known as Dario Smart Diabetes Management Solution, is a mobile, real-time, cloud-based, diabetes management solution based on a software application combined with Dario Smart Meter, a pocket-sized, blood glucose monitoring device. It offers Dario Engage software platform, where the company digitally engages with Dario users and assists them in monitoring their chronic illnesses, as well as provides them with coaching, support, digital communications; and real time alerts, trends, and pattern analysis. The company markets its products directly to consumer cash sales, as well as retail pharmacy, hospitals, and distributors; and through e-stores. DarioHealth Corp. has strategic partnership with CCS Medical. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was founded in 2011 and is headquartered in Caesarea, Israel.

Current Quote*
Last: $0.402
Change: -0.038
Book: $3.915
Volume: 22,951

As Of: 08/16 13:11 ET
*Quotes delayed by 20min.

Graphs for DRIO


3 Month Graph


6 Month Graph


1 Year Graph